JAK1/TYK2-IN-3 is a potent, selective, and orally active dual TYK2/JAK1 inhibitor with IC50 values of 6 nM and 37 nM, respectively; it exerts anti-inflammatory effects by modulating the expression of TYK2/JAK1-related genes and the differentiation of Th1, Th2, and Th17 cells.